期刊文献+
共找到1篇文章
< 1 >
每页显示 20 50 100
Metabolic disorders and hepatitis: Insights from a Mendelian randomization study
1
作者 Ling-Bo Liang Xiang-Ping Liu +1 位作者 ting-rui mao Qiao-Li Su 《World Journal of Gastrointestinal Surgery》 SCIE 2024年第6期1775-1790,共16页
BACKGROUND Hepatitis is a systemic disease that often results in various comorbidities.Meta-bolic disorders,the most common comorbidities in clinical practice,were selected for this study.AIM To investigate the causal... BACKGROUND Hepatitis is a systemic disease that often results in various comorbidities.Meta-bolic disorders,the most common comorbidities in clinical practice,were selected for this study.AIM To investigate the causal relationship between comorbidities and hepatitis trea-tment outcomes.METHODS A total of 23583378 single nucleotide polymorphisms from 1248743 cases and related summaries of genome-wide association studies were obtained from online public databases.A two-sample Mendelian randomization(MR)was performed to investigate causality between exposure[type 2 diabetes mellitus(T2D),hyperlipidemia,and hypertension]and outcome(chronic hepatitis B or C in-fections).RESULTS The data supported the causal relationship between comorbidities and hepatitis infections,which will affect the severity of hepatitis progression and will also provide a reference for clinical researchers.All three exposures showed a link with progression of both hepatitis B(T2D,P=0.851;hyperlipidemia,P=0.596;and hypertension,P=0.346)and hepatitis C(T2D,P=0.298;hyperlipidemia,P=0.141;and hypertension,P=0.035).CONCLUSION The results of MR support a possible causal relationship between different ex-posures(T2D,hyperlipidemia,and hypertension)and chronic hepatitis progression;however,the potential mechanisms still need to be elucidated. 展开更多
关键词 HEPATITIS COMORBIDITY Type 2 diabetes mellitus HYPERLIPIDEMIA HYPERTENSION
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部